Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 3/20 | 0.38 |
| ▸ | CES1 | P23141 | 3/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | GPR17 | Q13304 | 1/20 | 0.35 |
| ▸ | HTR1A | P08908 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | F7 | P08709 | 1/20 | 0.32 |
| ▸ | F3 | P13726 | 1/20 | 0.32 |
| ▸ | PRKAB2 | O43741 | 3/20 | 0.32 |
| ▸ | PRKAG1 | P54619 | 3/20 | 0.32 |
| ▸ | PRKAA2 | P54646 | 3/20 | 0.32 |
| ▸ | PRKAA1 | Q13131 | 3/20 | 0.32 |
| ▸ | PRKAG3 | Q9UGI9 | 3/20 | 0.32 |
| ▸ | PRKAG2 | Q9UGJ0 | 3/20 | 0.32 |
| ▸ | PRKAB1 | Q9Y478 | 3/20 | 0.32 |
| ▸ | CGAS | Q8N884 | 1/20 | 0.31 |
| ▸ | TDO2 | P48775 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13325448 | 0.84 | CES2 (0.38) | CES2CES1KDM4EGPR17HTR1A | |
| SCHEMBL25246999 | 0.81 | TUBB1 (0.37) | LMNAPRKAB2PRKAG1PRKAA2PRKAA1 | |
| SCHEMBL25748764 | 0.80 | HTR1A (0.39) | CES2CES1KDM4EGPR17HTR1A | |
| SCHEMBL31708153 | 0.79 | SLC22A6 (0.38) | KDM4EHTR1AALDH1A1LMNA | |
| SCHEMBL1732171 | 0.77 | HTR2A (0.47) | CES2CES1ALDH1A1 | |
| SCHEMBL25423247 | 0.76 | HTR1A (0.39) | CES2CES1GPR17HTR1AALDH1A1 | |
| SCHEMBL25748782 | 0.76 | HTR1A (0.36) | CES2CES1KDM4EGPR17HTR1A | |
| SCHEMBL25241237 | 0.74 | GPR84 (0.47) | CES2CES1KDM4EHTR1AF7 | |
| SCHEMBL25424025 | 0.74 | ALDH1A1 (0.49) | CES2CES1KDM4EALDH1A1LMNA | |
| SCHEMBL31077733 | 0.74 | ALDH1A1 (0.49) | CES2CES1KDM4EALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250101038-A1 | COMPOUNDS | Psylo Pty Ltd (AU) | 2025-03-27 | — | — | US | disclosed |
| CN-118715204-A | Compounds of formula (I) | 普赛洛私人有限公司 | 2024-09-27 | — | — | CN | disclosed |
| WO-2023115166-A1 | COMPOUNDS | Psylo Pty Ltd (AU) | 2023-06-29 | — | — | WO | disclosed |
| WO-2023115166-A1 | COMPOUNDS | Psylo Pty Ltd (AU) | 2023-06-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250101038-A1 | COMPOUNDS | NLN, SLC18A2, PYGB | CES2 27/4885CES1 1556/4885KDM4E 3243/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.